HCPCS code J0218 — Inj olipudase alfa-rpcp 1mg. Status: Active. Effective Apr 1, 2023. Source: CMS HCPCS Level II.

J0218

Active

Inj olipudase alfa-rpcp 1mg

Injection, olipudase alfa-rpcp, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Apr 1, 2023
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9113

MUE — Medically Unlikely Edits

Maximum units of J0218 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 460
Practitioner Services 460

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
58468-0050-01 Xenpozyme
58468-0051-01 Xenpozyme

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q2
    Inj olipudase alfa-rpcp 1mg